After contracting Covid-19, many people develop asthma with symptoms of cough, shortness of breath, and chest tightness, even though they have never had this disease before.
Read more »
Research from Sweden shows that after contracting Covid-19, the patient's brain removes a large number of synapses, thereby increasing the risk of mental disorders.
Read more »
Russia plans to announce the preliminary results of the Sputnik V vaccine test at the end of October, after the first six weeks of follow-up. The global Covid-19 vaccine race is more exciting than ever as Russia has a high chance of becoming the first country to publish data on phase 3 vaccine trials.
Read more »
Canada has signed agreements with six pharmaceutical companies to own potential Covid-19 vaccine "candidates" in the world. Although they do not know whether these vaccines are effective and safe or not because no "candidates" have been completed yet, the Government of Canada has decided to buy about 20-72 million doses of each type to store. In the event that one, or several "candidates" from the above 6 pharmaceutical companies are not eligible for marketing authorization, the number of doses pre-booked will be lower than expected.
Read more »
Representatives of the European pharmaceutical management agency said that even with an urgent evaluation of the two leading "candidates", it is difficult to complete it at the end of the year.
Read more »
The US pharmaceutical company said it would not patent its vaccine trials before the pandemic ended. Moderna's announcement on October 8 is seen as a move to allow other drug manufacturers to develop injections using their technology.
Read more »
China views the development of the nCoV vaccine as a "key political mission", with four out of 10 "candidates" moving rapidly to end-stage testing. Chinese President Xi Jinping has repeatedly urged the country's scientists to accelerate the research and development of the nCoV vaccine. Chinese medicine makers were also asked to view their work as a "political important task".
Read more »
RIO DE JANEIRO Larissa Bragança Itaborahy, a Covid-19 patient physician, is one of tens of thousands of people receiving the experimental nCoV vaccine. The reason Dr. Itaborahy (33) volunteered to try the nCoV vaccine from Sinovac, a "candidate" developed by China, is to fight doubts surrounding the safety and effectiveness of clinical trials. . She said that at present the world is not only facing the Covid-19 epidemic but also against the storm of false information.
Read more »
The second Russian vaccine uses only part of the nCoV protein instead of the whole virus, stimulating the immune system to produce antibodies without side effects. On October 15, Russia approved a second Covid-19 vaccine, called EpiVacCorona, developed by the Vector Institute. The vaccine contains a small portion of the protein of nCoV, called a peptide, that induces an immune response against Covid-19 and promotes the development of immunity.
Read more »
After being infected with nCoV in March, Michael Reagan completely lost his memories of his 12-day vacation in Paris, even though the trip had only happened a few weeks earlier. "I looked at all my pictures in Paris, trying to remember. We went to a Madonna show, to the Eiffel Tower and to the Tomb. And I don't remember anything, no memories left. "Anyway," said the 50-year-old vascular specialist.
Read more »



VACXIN VIETNAM JOINT STOCK COMPANY
Certificate of Business Registration No. 0107631488 by the Department of Planning and Investment City. Hanoi issued on 11/11/2016
Address: 180 Truong Chinh, Khuong Thuong Ward, Dong Da District, City. Hanoi
Mail: info@mode.edu.vn
Hotline: 028 7300 6595
Working time: From Monday to Sunday
From 7:30 - 17:00 (no lunch break)
117-119 Ly Chinh Thang, Ward 7, District 3, City. Ho Chi Minh
Copyright © 2016 by VACXIN VIETNAM JOINT STOCK COMPANY